id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-N-3771-0002,FDA,FDA-2018-N-3771,Report on the Performance of Drug and Biologics Firms in Conducting Postmarketing Requirements and Commitments,Notice,Notice of Availability,2019-08-07T04:00:00Z,2019,8,2019-08-07T04:00:00Z,,2019-08-08T14:33:13Z,2019-16878,0,0,0900006483e066e4